For an industry built on velocity — buy, optimise, exit, repeat — private equity has found itself parked. For the fourth consecutive year, profits returned to investors have declined. Distributions as a share of net asset value stood at 14% last year, according to Bain & Co Inc — the second-lowest level since the nadir of the 2008 financial crisis. And this stagnation has endured longer than the post-Lehman paralysis that once defined the industry’s darkest hour. The numbers are sobering. Approximately $3.8 trillion of assets remain unsold. Around 32,000 companies sit in portfolios worldwide. Holding periods have stretched to seven years, up from five or six as recently as 2021. Capital that once rotated briskly now lingers.

Liquidity, in private equity, is oxygen. And the air is thin. Deal value in 2025 rose 44% year-on-year to $904 billion, buoyed by large transactions — including the $56.6 billion buyout of Electronic Arts Inc. Yet beneath the headline figures, the engine sputters. The total number of deals fell 6% to 3,018. Cash reserves — dry powder — remain stubbornly elevated. Activity exists, but circulation does not.

One reason is the uncertainty triggered by President Donald Trump’s “Liberation Day” tariffs, which abruptly cooled negotiations that had appeared to be flourishing only months earlier. Markets dislike uncertainty. Private equity detests it. The roots of the malaise lie further back. The post-pandemic stimulus surge of 2021 briefly revived buyout activity, as cheap money and exuberant multiples fuelled transactions. But the 2022 rate shock altered the mathematics. Rising borrowing costs compressed valuations, complicated leverage structures and reduced exit opportunities. Without exits, distributions to investors slowed. Without distributions, fundraising faltered.

Fundraising fell 16% in 2025 to $395 billion — the fourth consecutive annual decline — even as infrastructure and secondary vehicles attracted incremental capital. Pension funds and endowments, once eager partners, have grown selective. They now seek net internal rates of return above 20%. In prior cycles, a company growing EBITDA by 5% annually could deliver acceptable returns.  In today’s environment of higher rates and tighter multiples, firms require sustained annual growth of 12% over five years to achieve equivalent outcomes. Twelve is the new five. That is not optimisation. It is a transformation.

The most promising assets have already been sold. What remains are companies with more complex narratives — less obvious trajectories, more uncertain exits. The longer they remain on balance sheets, the more internal rates of return erode. Beyond five or six years, IRRs lose their allure. Private equity thrives on disciplined alchemy: operational improvement, financial engineering, and timely disposal. But when the exits stall, the model strains. Returns compress. Capital remains trapped. Fundraising becomes an exercise in persuasion rather than momentum.

Yet the industry is not terminal. Private equity continues to offer diversification unavailable in increasingly concentrated public markets. That claim retains validity. But diversification is not liquidity. And liquidity is what investors crave. The paradox is stark. Private equity manages trillions. It commands influence across industries and geographies. It sits at the apex of modern capital allocation. And yet it is struggling to convert paper value into realised cash.

The backlog is not merely numerical. It is psychological. When $3.8 trillion waits for a bid, valuation becomes aspiration rather than transaction. Investors begin to question marks. General partners hesitate to crystallise losses. The equilibrium freezes. This is not a collapse. It is congestion. But in finance, congestion can metastasise. Extended holding periods compress IRRs. Lower IRRs deter fresh commitments. Reduced fundraising limits for new acquisitions. The virtuous cycle inverts. Private equity once promised perpetual compounding. Today, it resembles a motorway at capacity — powerful vehicles idling, engines running, exits distant. For now, the industry waits for the one variable it cannot manufacture: a decisive reopening of liquidity. Until then, the great machine of leveraged ambition remains stalled, surrounded not by crisis — but by accumulation. And accumulation, in excess, becomes its own risk.